Delivery Order SPE2DE24DA011-SPE2D626F711D
- Not listed
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,244.66 to Arthrex Inc. for FIBERSTITCH 1.5, Curved orthopedic surgical products. This fixed-price delivery order with economic price adjustment was issued on October 29, 2025, with a completion date of November 3, 2025, and is performed at Arthrex's Naples, Florida headquarters. The award carries no set-aside designation, reflecting Arthrex's established competitive position as a primary federal supplier of...
- The U.S. Department of Defense's Medical Supply Chain has awarded a $23,523.67 fixed-price delivery order to Arthrex Inc. for FIBERSTITCH 1.5, CURVED orthopedic surgical products, with an ultimate completion date of November 3, 2025. This delivery order, issued without set-aside designation, represents a task order under Arthrex's larger single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471M and effective through...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $18,994.62 to Arthrex Inc. for FIBERSTITCH 1.5, Curved orthopedic surgical products. This fixed-price delivery order with economic price adjustment was awarded on September 19, 2025, with an ultimate completion date of September 24, 2025. The work will be performed in Naples, Florida, where Arthrex maintains its global headquarters. This award was made without a set-aside designation, reflecting the...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $129,099.96 fixed-price delivery order with economic price adjustment to Arthrex Inc. for FIBERSTITCH 1.5, 24 DEGREE CURVE orthopedic surgical devices. The award, issued on September 22, 2025, with an ultimate completion date of September 25, 2025, represents a non-set-aside competitive procurement. Arthrex, a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, will perform this delivery order...
- Arthrex Inc. has been awarded a delivery order valued at $3,934.73 for FIBERSTITCH 1.5, Curved orthopedic surgical products under its existing Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on October 22, 2025, with an ultimate completion date of October 27, 2025, utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation. This delivery order represents a task order under Arthrex's comprehensive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $3,026.10 for FIBERSTITCH 1.5, Curved surgical products. Awarded on September 18, 2025, with an ultimate completion date of September 23, 2025, this delivery order was funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award carries no set-aside designation, reflecting Arthrex's competitive position...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for FIBERSTITCH 1.5, Curved orthopedic surgical products. Awarded on August 12, 2025, this fixed-price delivery order with economic price adjustment carries a ceiling value of $8,606.47 and is scheduled for completion by August 15, 2025. The contract does not utilize a set-aside designation, reflecting...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $19,375.91 delivery order by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, for FIBERSTITCH 1.5, 24 DEGREE CURVE products. The contract is classified as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of June 5, 2025. This award represents a task order issued under Arthrex's existing Indefinite...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $31,455.61 fixed-price delivery order with economic price adjustment to Arthrex Inc. for FIBERSTITCH 1.5, Curved surgical products. This delivery order, issued on September 9, 2025, with an ultimate completion date of September 12, 2025, is being fulfilled from the contractor's location in Naples, Florida. The award represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) valued at $471...
- The U.S. Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense, awarded a delivery order to Arthrex Inc. valued at $2,420.88 for FiberStitch 1.5 with a 24-degree curve surgical implant. Issued on August 7, 2025, this fixed-price delivery order with economic price adjustment provisions carries an ultimate completion date of August 12, 2025, and will be performed in Naples, Florida. The award was made without a set-aside designation, reflecting Arthrex's...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D626F711DDelivery Order
The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $2,093.19 to Arthrex Inc. for FIBERSTITCH 1.5, Curved surgical products. The award was issued on October 30, 2025, with an ultimate completion date of December 8, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, reflecting Arthrex's competitive standing in federal procurement. Performance will be executed at the company's Naples, Florida headquarters, where Arthrex manufactures minimally invasive orthopedic medical technologies and surgical instruments. This delivery order is issued under Arthrex's master Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, a comprehensive vehicle valued at $471.0 million and effective through September 1, 2029. Arthrex serves as prime contractor for this task order without subcontractors, supplying advanced orthopedic solutions to support Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. The company's portfolio includes surgical implants, arthroscopic instruments, joint replacement technologies, and specialized biologics that support comprehensive orthopedic surgical procedures across multiple specialties for military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/30/25 |